Daily use of an artificial intelligence by caregivers Prediction and personalization of the expected information to impact patients care
|
|
- Ira Lynch
- 5 years ago
- Views:
Transcription
1 Daily use of an artificial intelligence by caregivers Prediction and personalization of the expected information to impact patients care
2 Agenda 1. Drugs don t kill, bad usage does 2. Peut-on demander le diable à son médecin ou à son pharmacien? 3. Limitations of current search engines 4. Why using AI is a right approach? 5. Our Challenges 6. Our perspectives
3 Eric Baseilhac Journée du collectif Bon usage 22 mars 2018 «Drugs don t kill, bad usage does»
4 «All things are poison, and nothing is without poison, the dosage alone makes it so a thing is not a poison» Paracelse ( )
5 Informed drug usage, a public health issue Every year, drug related accidents are accountable for: 1.3M days of hospitalization in France deaths in Europe 2 79 B of expenditures in Europe 2 1. B Begaud et D Costagliola : Rapport sur la surveillance et le bon usage des medicaments en France ; Septembre 2013 ; La Documentation Française ; 2 MEMO/08/782 European Commission - Brussels, 10 December November Strengthening pharmacovigilance to reduce adverse effects of medicines 5
6 Avoidable medication errors says the WHO In England, alone, 237 millions medication errors /year 1 How to reduce these errors? Particularly through an immediate and accessible information 1. Government takes steps to reduce annual burden of medication errors in England, BMJ2018; 6
7 In practice <1 minute to optimize drug prescription
8 Nowadays, it s challenging for healthcare professionals to know everything there s to know about drugs drugs in France sources Numerous patients data Données GERS décembre 2017.
9 Peut-on demander le diable à son médecin ou à son pharmacien?
10 YES
11 AND NO
12 Devil s in the details in the official documentation Summary of Product Characteristics (SPC) : about 50 pages Up to 2 to 6 minutes for a practician to find the relevant information Tests réalisés en juin 2018 par des médecins du CHU d Amiens
13 Sometimes in medecine, more than a single answer to a question Datawise, and by precaution, the usage of zopiclone is unadvised during pregnancy regardless of the term. Treating a pregnant women: Zopiclone can be used regardless of the pregnancy term.
14 A couple of tool to support our decisions but mainly for medication interactions Hundreds of different question types: Drug usage during breastfeeding Does this drug need a secured prescription? How to handle a cold chain interruption? Which dosage for a paediatric use? Does this drug make one photosensitized?
15 An infinity of drug related questions 8 billions requests in the major search engines, each year Y a-t-il une contre-indication à la prise d Haldol avec Amiodarone? Peut-on prescrire Ioméron à un patient diabétique? Quel risque à l'exposition au soleil avec le Kétum gel? L Oméprazole TEVA contient-il du lactose? Peut-on écraser les comprimés de Sinemet LP?
16 Limitations of current search engines
17 More than frequent incorrect answers!!!!
18 Sometimes dangerous answers 18
19 On search engines, answers to the same question are highly driven by the wording
20 Another example
21 Search engines do not identify the intent of question 21
22 Why using AI is a right approach?
23 Posos is today built by 11 pharmacists and engineers in AI 23
24 Posos approach BECOME THE LEADING DRUG RELATED INFORMATION REFERENCE A complete and accurate answer in less than a seconde INFORMED DECISION MAKING PROCESS Always neutral Oriented to a thorough answer CONSTANT IMPROVEMENT OF OUR SOLUTION State of the art NLP algorithms Reinforcement learning solution User feedback analysis 24
25 Tests réalisés en juin 2018 par des médecins du CHU d Amiens An answer given in a second or less
26 Dedicated natural language processing algorithms that understand drug-related questions and give personnalized answers Reinforcement learning system Information in the question (drug, pathology) Drug related question 1 2 Requested info Context Answers Artificial neuronal network Patient data (on-going treatments, biological results, genetic profile ) 100+ sources of information
27 Examples of drug-related questions embedding
28 Contextualization of the question 1. By Named Entity Recognition Puis-je prescrire Aldactone à ma patiente insuffisante rénale et déjà traitée par Cibacene? 2. With additional patient data Concomitant treatments Biological results Weight Age Genetic profile
29 Reinforcement learning system Posos is used by hundreds of healthcare profesionnals Experimentation at Amiens CHU Pharmacists and practicians beta testers
30 Our Challenges
31 Our daily challenges Updates given the Agence Nationale de sécurité du Médicament et des produits de santé (ANSM) = Hospital Information System (15+ years outdated) = NLP research challenge =
32 Our R&D challenges First Biomedical NER Recognition) in French (Named Entity Patient data contextualized questions A complete multilingual biomedical information retrieval system
33 Our perspectives
34 1. Making it possible to immediately answer any drug-related question, enabling for each and everyone a better healthcare 2. Increase knowledge about issues and needs related to the prescription, dispensing and use of medicines
35 We re hiring! POSOS Amiens Le Lab - 60 rue de la vallée Amiens T: M: hello@posos.fr
Updates on take-home naloxone in France Anne-Claire BRISACIER OFDT
Updates on take-home naloxone in France Anne-Claire BRISACIER OFDT French Monitoring Center for Drugs and Drug addiction EMCDDA DRD national expert Meeting Lisbon 18-20 September 2017 Background 1977 MA
More informationELLCIE HEALTHY : smart connected eyewear with Artificial Intelligence
PRESS FILE ELLCIE HEALTHY : smart connected eyewear with Artificial Intelligence 09/01/2019 DROWSINESS AND VIGILANCE Falling asleep is one of the major factors of danger on the road as drowsiness at the
More informationPRAC non-interventional imposed PASS final study report assessment report
1 December 2016 EMA/101726/2017 Pharmacovigilance Risk Assessment Committee (PRAC) PRAC non-interventional imposed PASS final study report assessment report Cyproterone/ethinylestradiol Active substance:
More informationPHARMACOVIGILANCE RISK ASSESSMENT COMMITTEE (PRAC) List of questions to be addressed by healthcare professional representative organisations
12 April 2018 EMA/227227/2018 PHARMACOVIGILANCE RISK ASSESSMENT COMMITTEE (PRAC) List of questions to be addressed by healthcare professional representative Article 31 of Directive 2001/83/EC resulting
More informationReport to/rapport au : Ottawa Board of Health Conseil de santé d Ottawa. Monday October /le lundi 15 octobre 2012
Report to/rapport au : Ottawa Board of Health Conseil de santé d Ottawa Monday October 15 2012/le lundi 15 octobre 2012 Submitted by/soumis par : Dr./D r Isra Levy, Medical Officer of Health/Médecin chef
More informationHow to prevent iatrogenic risk? benzodiazepine dependence. Aline CORVOL CHU Rennes UMR 6051,
How to prevent iatrogenic risk? benzodiazepine dependence Aline CORVOL CHU Rennes UMR 6051, aline.corvol@chu-rennes.fr CONFLICT OF INTEREST DISCLOSURE I have no potential conflict of interest to report
More informationNotification of a Body in the framework of a technical harmonization directive
Notification of a Body in the framework of a technical harmonization directive From : ANSM : Agence Nationale de Sécurité du Médicament et des produits de santé - Direction de l'inspection 143, 147, Boulevard
More informationPRAC non-interventional imposed PASS final study report assessment report
1 December 2016 EMA/101714/2017 Pharmacovigilance Risk Assessment Committee (PRAC) PRAC non-interventional imposed PASS final study report assessment report Active substance: cyproterone/ethinylestradiol
More informationSUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT SPASMAG, capsule 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Magnesium sulphate trihydrate... 423.5 mg quantity equivalent to elemental
More information1. Product Name. 2. Product Code. 3. Colour. 4. Brief Description. 5. Contents. 6. Snoezelen Stimulations. Single Panel Porter.
1. Product Name Single Panel Porter 2. Product Code 18518 3. Colour As shown 4. Brief Description One panel can be used at one time and placed anywhere in a room. 5. Contents 1 x Porter 4 x Screws Please
More informationHow to (re)connect parallel universes?
3 rd International Conference on evidence-based policy in long-term care Session : Health and social care integration Health and social care policies for people with chronic conditions in France : How
More informationZopiclone for sale in uk
Zopiclone for sale in uk The Borg System is 100 % Zopiclone for sale in uk Zopiclone is a nonbenzodiazepine hypnotic agent used in the treatment of insomnia. Zopiclone is molecularly distinct from benzodiazepine
More informationDelayed hemolytic transfusion reaction in the French hemovigilance system
Delayed hemolytic transfusion reaction in the French hemovigilance system C. Rieux, G. Brittenham, D. Bachir, E. De Meyer, K. Boudjedir for the French hemovigilance network First Seminar on delayed hemolytic
More informationPharmacovigilance Methods and Post-Authorisation Safety Studies
Pharmacovigilance Methods and Post-Authorisation Safety Studies Alex Dodoo Director, WHO Collaborating Centre for Advocacy and Training in Pharmacovigilance Accra, Ghana Objectives At the end of this module
More informationPublic Perceptions of the Iodine Tablets Distribution Around French Nuclear Power Plants
Public Perceptions of the Iodine Tablets Distribution Around French Nuclear Power Plants S.Charron, D. Morin and J. Brenot Institute for Protection and Nuclear Safety (IPSN) BP 6, 92265 Fontenay-aux-Roses,
More informationOpinion 23 July 2014
The legally binding text is the original French version TRANSPARENCY COMMITTEE Opinion 23 July 2014 ACADIONE 250 mg, sugar-coated tablet Bottle of 120 (CIP: 34009 329 390 7 7) Applicant: SANOFI-AVENTIS
More informationWHICH VASCULAR ACCESS FOR HOME HD?
WHICH VASCULAR ACCESS FOR HOME HD? Th LOBBEDEZ, Clémence BECHADE, M FICHEUX Néphrologie-Dialyse-Transplantation, CHU de CAEN Bruxelles 06-07 Juin 2018 Follow us on tweeter #NDTCAEN Why this question?
More informationMEDICINES PROMOTION AND RATIONAL USE : The Spanish Experience JOSE LUIS DOPICO
MEDICINES PROMOTION AND RATIONAL USE : The Spanish Experience JOSE LUIS DOPICO LEGAL FRAMEWORK General Health Act (1986): Established a National Health System in Spain in accordance with the following
More informationIn an attempt to control pharmaceutical
n 128 - December 2007 Delisting of mucolytics and expectorants: what is the impact on general practitioners prescribing? Marion Devaux, Nathalie Grandfils, Catherine Sermet Following the round of delisting
More informationExecutive Summary Background: The Costs and Damage Caused by Drug Diversion
Are We Doing Enough? Executive Summary In 2017, Porter Research conducted a survey about the theft of narcotics by US healthcare workers. Onehundred fifty health care professionals, representing over one-hundred
More informationExternal Events Excluding Earthquakes in the Design of Nuclear Installations (DS498)
L atome pour la paix et le développement Vienna International Centre, PO Box 100, 1400 Vienna, Austria Phone : (+43 1) 2600 Fax: (+43 1) 26007 Email: Official.Mail@iaea.org Internet: http://www.iaea.org
More informationRevision of seven closely interrelated Safety Guides on the Operation of Nuclear Power Plants: NS-G-2.2 to 2.6, NS-G-2.8 and NS-G-2.
L atome pour la paix et le développement Vienna International Centre, PO Box 100, 1400 Vienna, Austria Phone: (+43 1) 2600 Fax: (+43 1) 26007 Email: Official.Mail@iaea.org Internet: http://www.iaea.org
More informationBalancing access, quality and prevention of diversion of OST in Europe: a comparative analysis
Balancing access, quality and prevention of diversion of OST in Europe: a comparative analysis Access to OST Types of OST in France : High dose buprenorphine (HDB) (65%) Suboxone : HDB + naloxone (3%)
More informationHow to improve hand hygiene in a limited resources environment? Example from Senegal
How to improve hand hygiene in a limited resources environment? Example from Senegal Prof Babacar NDOYE ICAN Board 5th ICAN/ICAZ/ISC Conference Harare, 3-7 November, 2014 Page 1 OUTLINE I. Background II.
More informationSeismic Hazards in Site Evaluation for Nuclear Installations (DS507)
L atome pour la paix et le développement Vienna International Centre, PO Box 100, 1400 Vienna, Austria Phone : (+43 1) 2600 Fax: (+43 1) 26007 Email: Official.Mail@iaea.org Internet: http://www.iaea.org
More informationUpdate on the revision of the new package leaflet (PL) template. An agency of the European Union
Update on the revision of the new package leaflet (PL) template An agency of the European Union Contents Regulatory background New QRD package leaflet template -Origin - Contents and structure 2 Regulatory
More informationA L C O H O L A N D H E A LT H ALCOHOL AND SENIORS
ALCOHOL AND SENIORS TABLE OF CONTENTS Introduction 3 Alcohol and seniors 4 Seniors drinking habits 5 Identifying drinking problems among seniors 7 Abusive and dangerous drinking among seniors 8 Research
More informationFAMILY MEDICINE GROUPS AND VISITS TO THE EMERGENCY DEPARTMENT AMONG DIABETICS IN QUEBEC BETWEEN 2000 AND 2011
FAMILY MEDICINE GROUPS AND VISITS TO THE EMERGENCY DEPARTMENT AMONG DIABETICS IN QUEBEC BETWEEN 2000 AND 2011 Renee Carter, Ph.D. candidate, McGill University Amélie Quesnel-Vallée, Ph.D., McGill University
More informationHow many wellbutrin will kill you
Toggle navigation How many wellbutrin will kill you 7-3-2012 If you are thinking about harming yourself, there are 6 things you need to know before you do I need you to help me kill myself. The room is
More informationHow Health2.0 may contribute to the empowerment of informed citizen. Comment le Health2.0 peut contribuer à l autonomie éclairée du citoyen
Non Governmental Organization Quality of health related information on the Web How Health2.0 may contribute to the empowerment of informed citizen Comment le Health2.0 peut contribuer à l autonomie éclairée
More informationRisk Classification Modeling to Combat Opioid Abuse
Risk Classification Modeling to Combat Opioid Abuse Improve Data Sharing to Identify High-Risk Prescribers of Opioids Christopher Sterling Chief Statistician NCI, Inc. www.nciinc.com 11730 Plaza America
More informationSUMMARY RECORD OF THE STANDING COMMITTEE ON THE FOOD CHAIN AND ANIMAL HEALTH HELD IN BRUSSELS ON 16 NOVEMBER (Section Animal Health and Welfare)
SANCO D.1(06)D/410145 SUMMARY RECORD OF THE STANDING COMMITTEE ON THE FOOD CHAIN AND ANIMAL HEALTH HELD IN BRUSSELS ON 16 NOVEMBER 2005 (Section Animal Health and Welfare) President: Bernard Van Goethem
More informationHPV year 1 in Quebec Different perspectives, different outcomes. Monique Landry MD Ministry of Health of Quebec June 2009
HPV year 1 in Quebec Different perspectives, different outcomes Monique Landry MD Ministry of Health of Quebec June 2009 Outline The program The preparation The results The hypothesis The evaluation THE
More informationCH - 1 Linda Suydam, DPA CHPA Overview and Approach
CH - 1 Linda Suydam, DPA CHPA Overview and Approach President Consumer Healthcare Products Association CHPA Acetaminophen Task Group CH - 2 Bayer Healthcare LLC GlaxoSmithKline McNeil Consumer Healthcare
More informationRealization of medication history in the emergency departement
Realization of medication history in the emergency departement Evaluation the impact of a hospital pharmacist on the medication history of patients admitted to emergency departments: a prospective interventional
More informationThe Danish Medicines Agency s availability strategy
låst DECEMBER 2016 The Danish Medicines Agency s availability strategy 2017 2021 Danish Medicines Agency, 2016 This publication may be freely quoted with appropriate acknowledgement of the source. Images
More informationTraitement de 2ème ligne du cancer colorectal métastatique : nouvelles données cliniques en 2018
GR DIG 2017 Traitement de 2ème ligne du cancer colorectal métastatique : nouvelles données cliniques en 2018 9 décembre 2017 Benoist Chibaudel Oncologie Médicale Institut Hospitalier Franco-Britannique,
More informationAn overview of occupational health surveillance in the United States: an evolving system of systems
Cette présentation a été effectuée le 4 décembre 2018 au cours de la journée «Nouvelles perspectives en surveillance et contrôle des maladies pulmonaires au Québec» dans le cadre des 22es Journées annuelles
More informationLibrary of ALCOHOL HEALTH WARNING LABELS
Library of ALCOHOL HEALTH WARNING LABELS Page - 1 The European Alcohol Policy Alliance (EUROCARE) is an alliance of non- governmental and public health organisations with around 51 member organisations
More informationGetting the best from the medicines you buy
Getting the best from the medicines you buy You can buy many medicines without needing to see your doctor. These are often called over-the-counter medicines. They are safe and effective as long as you
More informationTypology of drug misuses created from information available in health fora
Typology of drug misuses created from information available in health fora Élise BIGEARD a,b,1, Natalia GRABAR a, Frantz THIESSARD b a Univ. Lille, CNRS, UMR 8163 - STL - Savoirs Textes Langage, F-59000
More informationCancer Control Joint Action Policy Conference Cancer Survivorship: a policy dialogue. Survivorship and the French example
Cancer Control Joint Action Policy Conference Cancer Survivorship: a policy dialogue Survivorship and the French example Committee of the Regions - Brussels - 13/05/2015 STRUCTURE OF THE PRESENTATION I.
More informationKEY DIFFERENCES BETWEEN THE NEW MEDICAL DEVICE AND THE OTC REGULATIONS IN EUROPE
RNI Conseil 2017 Tous droits réservés Toute reproduction interdite sans l'autorisation de l'auteur. KEY DIFFERENCES BETWEEN THE NEW MEDICAL DEVICE AND THE OTC REGULATIONS IN EUROPE Anne Laure TARDY, PhD
More informationTRANSPARENCY COMMITTEE
The legally binding text is the original French version TRANSPARENCY COMMITTEE Opinion 17 September 2014 ALPRESS LP 2.5 mg, prolonged-release osmotic tablet B/30 (CIP: 331 177-5) B/90 (CIP: 372 965-8)
More informationPrepare Your Practice To Fight Flu: Make a Strong Influenza Vaccine Recommendation and Improve Your Influenza Vaccination Rates This Season
Prepare Your Practice To Fight Flu: Make a Strong Influenza Vaccine Recommendation and Improve Your Influenza Vaccination Rates This Season The thing that motivates me to FIGHT FLU is the ability to prevent
More informationLe Bon Usage (French Edition) By Maurice Grevisse READ ONLINE
Le Bon Usage (French Edition) By Maurice Grevisse READ ONLINE If you are searched for a ebook by Maurice Grevisse Le Bon Usage (French Edition) in pdf form, then you have come on to correct site. We furnish
More informationat the University Hospital (CHU) of Besançon
CHRU centre hospitalier régional universitaire Research & Innovation at the University Hospital (CHU) of Besançon THINK, INNOVATE, DIFFUSE, SHARE Meeting health challenges for better care Biotherapy module
More informationDispensing and administration of emergency opioid antagonist without a
68-7-23. Dispensing and administration of emergency opioid antagonist without a prescription. (a) A pharmacist may dispense an FDA-approved emergency opioid antagonist and the necessary medical supplies
More informationSafety and usability of packaging and labelling:
Paris, 29 November 2012 Safety and usability of packaging and labelling: assessment is required prior to marketing authorisation for all medicinal products, not just for copies of existing drugs Poor packaging
More informationAlcohol involvement in pedestrian accidents in France
Alcohol involvement in pedestrian accidents in France Helene FONTAINE and Yves GOURLET INRETS, 94114 Arcueil, Cedex, FRANCE For 25 years the number o f pedestrians killed on the roads has decreased in
More informationConsumer Labelling of alcoholic beverages A review of practices in Europe
Consumer Labelling of alcoholic beverages A review of practices in Europe European Alcohol and Health Forum, Brussels 8. April 2011 Walter Farke (MPH) Deutsches Institut für Sucht- und Präventionsforschung
More informationSocial Media Mining for Toxicovigilance
Social Media Mining for Toxicovigilance Automatic Monitoring of Prescription Medication Abuse from Twitter Abeed Sarker (@sarkerabeed) Health Language Processing Lab Research Associate Department of Biostatistics,
More informationOpinion 19 February 2014
The legally binding text is the original French version TRANSPARENCY COMMITTEE Opinion 19 February 2014 EURARTESIM 320 mg/40 mg, film-coated tablet B/12 tablets (CIP: 34009 217 519 8 7) Applicant: SIGMA-TAU
More information590 La Revue de Santé de la Méditerranée orientale, Vol. 14, N o 3, 2008
590 La Revue de Santé de la Méditerranée orientale, Vol. 4, N o 3, 2008 Rubella serology in pregnant women attending health centres of Tehran University of Medical Sciences F. Majlessi, A. Batebi, M. Shariat,
More informationWebinar. Cellular Medicine & HIV/AIDS. Fabrice Leu N.D
Webinar Cellular Medicine & HIV/AIDS Fabrice Leu N.D Summary What is HIV? What is AIDS? What causes HIV/AIDS? What is the orthodox medical approach? How to stop AIDS with Cellular Medicine Dr. Rath s book
More informationHow to Build a Channel of Effective Doctor Patient Communication
How to Build a Channel of Effective Doctor Patient Communication Written by medmonthly on July 31, 2015 in Features Effective communication is one of the most important facets of a doctor patient relationship.
More informationRapid Assessment of Sexual and Reproductive Health
NIGER Rapid Assessment of Sexual and Reproductive Health and HIV Linkages This summary highlights the experiences, results and actions from the implementation of the Rapid Assessment Tool for Sexual and
More informationSubmission Date: 18 July 2008 at: 14:17
Submission Date: 18 July 2008 at: 14:17 Questionnaire about Institutions partners SECTION 1 Official name 1 1 Provide the name of the organization such as the Ministry of Health or Public Health Institute
More informationTrends and Challenges: The Kentucky Opioid Crisis. Jason Smith, MD PhD University of Louisville
Trends and Challenges: The Kentucky Opioid Crisis Jason Smith, MD PhD University of Louisville Brief Introduction I am by no means an expert I have no financial disclosures Jokes are meant to be lighthearted
More informationUnderstand Medication and Prescriptions
Workbook 1 Understand Medication and Prescriptions Accountability Storage Administration Prescription Supply Legislation Level 2 Certificate in Understanding the Safe Handling of Medicines 1 L4W 2013 Information
More informationGood Health & Well-Being. By Alexandra Russo
Good Health & Well-Being By Alexandra Russo SDG 3 Goal 3 aims to ensure healthy living and promote well-being for all at all ages There are 9 targets associated with SDG 3 The targets encompass a wide
More information2007 : Became Poultry Corporate Marketing Director. Ceva Sante Animale, France
Dr. Sylvain Comte Poultry Corporate Marketing Director Ceva Sante Animale, France Graduated as a Veterinary in 1993 from National Veterinary School of Nantes France Master of science in Physiology and
More informationThe Impact of the Opioid Crisis. Deborah A. McMahan, MD Health Commissioner Allen County Department of Health
The Impact of the Opioid Crisis Deborah A. McMahan, MD Health Commissioner Allen County Department of Health Agenda How This Mess Started Scope of the Problem Why We Should Care -- Impact How This Mess
More informationNOVEL MEDICATION FOR NEUROPATHIC PAIN
NOVEL MEDICATION FOR NEUROPATHIC PAIN NRD.E1 a treatment for diabetic related neuropathic pain Novaremed s Dr Eli Kaplan shares research on NRD.E1 and explains how it can help to treat diabetic related
More informationFREQUENTLY ASKED QUESTIONS Naturopathic Profession Regulation Proposed Key Elements
FREQUENTLY ASKED QUESTIONS Naturopathic Profession Regulation Proposed Key Elements July 2016 PROPOSED KEY ELEMENTS Q. What are key elements? A. Key elements cover the most important parts of the proposed
More informationThe legally binding text is the original French version
The legally binding text is the original French version TRANSPARENCY COMMITTEE Opinion 28 March 2007 FACTANE 100 I.U. /ml, powder and solvent for solution for injection Box of 1 2.5 ml vial (CIP: 562 115-5)
More informationFavoriser le changement et la performance grâce aux indicateurs de qualité
Favoriser le changement et la performance grâce aux indicateurs de qualité Pascal Briot Direction médicale et qualité Direction des finances Pascal.briot@hcuge.ch +41 (0) 22 372 90 07 14 novembre 2017
More informationPart VI: Summary of the risk management plan by product
Part VI: Summary of the risk management plan by product VI.1 Elements for summary tables in the EPAR VI.1.1 Summary table of Safety concerns Summary of safety concerns Important identified risks Hepatotoxic
More informationL atome pour la paix. Preparedness and Response for an Emergency during the Transport of Radioactive Material (DS469)
L atome pour la paix Vienna International Centre, PO Box 100, 1400 Vienna, Austria Phone: (+43 1) 2600 Fax: (+43 1) 26007 Email: Official.Mail@iaea.org Internet: http://www.iaea.org In reply please refer
More informationUse of abatacept in rheumatoid arthritis - patient information
Practical management of patients receiving abatacept 1 Use of abatacept in rheumatoid arthritis - patient information Evidence-based Medicine Official Recommendations Expert opinion Key points 1. Abatacept
More informationThe quality of health information on the Web: a case for regulation? Célia Boyer Executive Director
The quality of health information on the Web: a case for regulation? Célia Boyer Executive Director Outline Online Health Information Presentation of HON Health Website Certification The HONcode Database
More informationFalls Risk Screening, Assessment, and Referral
Falls Risk Screening, Assessment, and Referral Kady Reese, MPH, CPHQ Lana Comstock, MSN, RN Iowa Fall Symposium July 13, 2017 Goals Identify risk assessment tools for varied patient populations Recite
More informationFasenra. 30 mg, solution for injection. Summary of the Risk Management Plan (RMP) for Fasenra (Benralizumab)
Fasenra 30 mg, solution for injection Summary of the Risk Management Plan (RMP) for Fasenra (Benralizumab) Document Version: 1.0 Document Date: 08-June-2018 Summary of the risk management plan (RMP) for
More informationEnhancing Well-Being in Older Adults Living with Dementia. G. Allen Power, MD, FACP Rochester, NY Consumer Voice 2013 Conference November 27 th, 2013
Enhancing Well-Being in Older Adults Living with Dementia G. Allen Power, MD, FACP Rochester, NY Consumer Voice 2013 Conference November 27 th, 2013 Objective To change your minds about people whose minds
More informationElectronic Test Orders and Results (ETOR)
Electronic Test Orders and Results (ETOR) Portal for Antibiotic Resistance (AR) Lab Network Problem Statement Antibiotic-resistant (AR) bacteria germs that don t respond to the drugs developed to kill
More informationOpening Remarks. Second Regional Consultation on Compulsory Centres for Drug Users
Opening Remarks Gary Lewis UNODC Regional Representative East Asia and the Pacific Second Regional Consultation on Compulsory Centres for Drug Users Kuala Lumpur Malaysia 1 October 2012 Honourable Deputy
More informationWho benefits from the European Paediatric Regulation?
Paris, 28 November 2012 Who benefits from the European Paediatric Regulation? Response to the European Commission s public consultation on the lessons learnt from the first 5 years of application of the
More informationSecond China-EU Symposium on Gender Equality under HPPD
Boosting Employment and Entrepreneurship of Young Women Shanghai, 14 November 2017 Ms Annelies Pierrot Bults, Executive Member of the European Women s Lobby Madam President of the All China Women s Federation,
More informationPercutaneous Left Atrial appendage occlusion and anticoagulation therapy Nicolas Lellouche, MD, PhD
Percutaneous Left Atrial appendage occlusion and anticoagulation therapy Nicolas Lellouche, MD, PhD Fédération de Cardiologie Hôpital Henri Mondor Créteil Atrial Fibrillation is a major cause of Stroke
More information2017 Commonwealth Fund International Health Policy Survey of Older Adults in 11 Countries
2017 Commonwealth Fund International Health Policy Survey of Older Adults in 11 Countries Media Teleconference November 14, 2017 Robin Osborn Vice President and Director International Program in Health
More informationMOTION FOR A RESOLUTION
EUROPEAN PARLIAMT 2009-2014 Plenary sitting 07.3.2012 B7-0000/2012 MOTION FOR A RESOLUTION further to Question for Oral Answer B7-0000/2012 pursuant to Rule 115(5) of the Rules of Procedure on Defective
More informationMedroxyprogesterone 10 mg and menopause
Medroxyprogesterone 10 mg and menopause Search Millions of women worldwide, many in their teenage years, have been using the longacting, injectable depot medroxyprogesterone. L acétate de médroxyprogestérone
More informationWhat public health benefits could be secured by using universal labelling & packaging for influenza pandemic vaccines?
What public health benefits could be secured by using universal labelling & packaging for influenza pandemic vaccines? Workshop on the joint procurement of medical countermeasures 29 April 2015, Luxembourg
More informationSANOFI PASTEUR, LEADING PROVIDER OF SEASONAL INFLUENZA VACCINES
FACT SHEET SANOFI PASTEUR, LEADING PROVIDER OF SEASONAL INFLUENZA VACCINES WORLD S LEADING INFLUENZA VACCINE MANUFACTURER Annual production capacity of Sanofi Pasteur seasonal influenza vaccines have doubled
More informationHealth security and the IHR: a humanitarian perspective
Health security and the IHR: a humanitarian perspective European Health Forum Gastein 2 October 2015 Forum 8: Securing health - Importance of the implementation of the IHR Philippe Calain, MD, PhD, MSc,
More informationResults of the 10 th HON survey on health and medical Internet use
Results of the 10 th HON survey on health and medical Internet use Natalia PLETNEVA a, Sarah CRUCHET a, Maria-Ana SIMONET a, Maki KAJIWARA a, Célia BOYER a a Health on the Net Foundation, Geneva, Switzerland
More informationFOR THE HEALTHCARE PROFESSIONALS
FOR THE HEALTHCARE PROFESSIONALS WHEN DRUG SAFETY IS YOUR CONCERN EVIDENCE BASED DECISION SUPPORT FOR DRUG THERAPY MEDBASE LTD PRODUCES MEDICAL DATABASES FOR HEALTHCARE PROFESSIONALS AND PATIENTS TO EN-
More informationPr Fadi FARHAT Service de Chirurgie Cardiovasculaire Adulte et Transplantation Hôpital Louis Pradel, Bron, FRANCE. NOM Intitulé du topo Date.
5 ème Journée Scientifique de la Réunion de Concertation Pluridisciplinaire sur l Endocardite Infectieuse du CHU de Lyon ENDOCARDITE AIGUE INFECTIEUSE Y A-T-IL UN SUBSTITUT VALVULAIRE IDEAL? Pr Fadi FARHAT
More informationBLOOD TRANSFUSIONS. Answers. To Your. Questions
BLOOD TRANSFUSIONS Answers To Your Questions Answers to Your Questions This brochure is intended for people who may need a blood or blood product transfusion and for those who regularly receive transfusions.
More information5 ORGANISING USERS CLUBS European Users Clubs National Users Clubs Local Users Clubs
5 ORGANISING USERS CLUBS European Users Clubs National Users Clubs Local Users Clubs How to organise a Users Club You have already carried out a successful local communication campaign, the local actors
More informationHEALTH, GROWTH, AND MEDICINES. Angus Deaton 49 th International Conference in Memory of Franco Modigliani Brescia, 17 th June, 2016
1 HEALTH, GROWTH, AND MEDICINES Angus Deaton 49 th International Conference in Memory of Franco Modigliani Brescia, 17 th June, 2016 Health, growth, and medicines Does economic growth promote health? Is
More informationCDC Strategies for Protecting Older Americans
CDC Strategies for Protecting Older Americans Grant Baldwin, PhD, MPH Director, Division of Unintentional Injury Prevention National Center for Injury Prevention and Control Centers for Disease Control
More informationPatrick J. Sullivan, President & CEO March 7, 2016 Raymond James 37 th Annual Institutional Conference
Patrick J. Sullivan, President & CEO March 7, 2016 Raymond James 37 th Annual Institutional Conference Forward Looking Statement This presentation may contain forward-looking statements concerning Insulet's
More informationMarc Steben, President Marie-Claude Drouin, Coordinator STBBIs Committee/Unit
Working from a sexual health or harm reduction perspective: Integration of HIV, HCV and other sexually transmitted and bloodborne infections (STBBIs): Evidence and practice Marc Steben, President Marie-Claude
More informationMedication Management When Caring for Seniors at Home
Medication Management When Caring for Seniors at Home White Paper May 24, 2013 2013 Physician s Choice Private Duty http://private-duty.pchhc.com 1 Proper medication management for seniors who live at
More informationUne approche intelligente pour le monitorage de l'information sur la santé de la population et le système de la santé
Une approche intelligente pour le monitorage de l'information sur la santé de la population et le système de la santé David Buckeridge, MD PhD FRCPC Associate Professor, McGill University CIHR Chair, Applied
More informationKey Messages for World Malaria Day 2009
INFORMATION RBM/WG/2009/INF.12 10 APR 2009 Draft document General distribution English Only Key Messages for World Malaria Day 2009 Counting Malaria Out to Reaching the 2010 Targets On the occasion of
More informationWORKSHOP S THEME: ANXIETY 1 (Week 1)
WORKSHOP S THEME: ANXIETY 1 (Week 1) Help the clients awareness to discriminate between notions related to anxiety. Identify the elements generating a situation of stress Distinguish notions relating to
More informationCommunication with Cognitively Impaired Clients For CNAs
Communication with Cognitively Impaired Clients For CNAs This course has been awarded one (1.0) contact hour. This course expires on August 31, 2017. Copyright 2005 by RN.com. All Rights Reserved. Reproduction
More informationDrinking and Driving in France in : Changes in The Decade and New Perspectives
Drinking and Driving in France in 1999-2000 : Changes in The Decade and New Perspectives M. B. Biecheler-Fretel 1, F. Facy 2, J. F. Peytavin 1 1 INRETS-DERA, 2, avenue du Général Malleret-Joinville, F-94
More information